# De Novo Splice Site Variant of TCF12 in a Boy With Isolated Kallmann Syndrome

**Authors:** Erina Suzuki, Hirohito Shima, Aki Ueda, Kazuhiko Nakabayashi, Keiko Matsubara, Yoko Kuroki, Junko Kanno, Maki Fukami

PMC · DOI: 10.1155/crie/2350842 · Case Reports in Endocrinology · 2025-07-03

## TL;DR

A de novo mutation in the TCF12 gene is linked to isolated Kallmann syndrome in a boy with no other symptoms.

## Contribution

This is the first report of a TCF12 splice site variant causing isolated Kallmann syndrome.

## Key findings

- A de novo TCF12 splice site variant (c.391–1G >A) was identified in a patient with Kallmann syndrome.
- The variant was predicted to cause a frameshift and premature termination, and was classified as pathogenic.
- No other rare variants in known Kallmann syndrome or CHH genes were found in the patient.

## Abstract

Background: Kallmann syndrome is a rare endocrinopathy characterized by congenital hypogonadotropic hypogonadism (CHH) and olfactory dysfunction. The current understanding of the genetic basis of Kallmann syndrome is fragmentary. TCF12 is a causative gene for autosomal dominant craniosynostosis with various complications. Although recent studies identified rare nucleotide substitutions and indels of TCF12 in a few families with CHH and additional clinical features, the significance of TCF12 variants as the cause of Kallmann syndrome remains uncertain.

Case Presentation: A Japanese boy exhibited bilateral cryptorchidism and micropenis at birth. He was otherwise healthy and had normal developmental milestones. At 11 years of age, he showed no pubertal signs. Physical examinations detected no clinical abnormalities except hyposmia. Brain imaging suggested olfactory bulb hypoplasia, but no other anomalies. A gonadotropin-releasing hormone (GnRH) stimulation test yielded low responses of gonadotropins. Whole-exome sequencing (WES) identified a hitherto unreported de novo heterozygous substitution at a splice acceptor site of TCF12 (c.391–1G >A). This variant was predicted to cause a frameshift and resultant premature termination (p.Ser132ProfsTer38) and was assessed as pathogenic, according to the ACMG/AMP 2015 guidelines. The patient carried no rare variants in other genes previously associated with Kallmann syndrome or CHH.

Conclusion: These results broaden the mutation spectrum of TCF12. More importantly, this study argues for the etiological relationship between TCF12 variants and isolated Kallmann syndrome.

## Linked entities

- **Genes:** TCF12 (transcription factor 12) [NCBI Gene 6938]
- **Diseases:** Kallmann syndrome (MONDO:0018800), congenital hypogonadotropic hypogonadism (MONDO:0015770), craniosynostosis (MONDO:0015469)

## Full-text entities

- **Genes:** GNRH1 (gonadotropin releasing hormone 1) [NCBI Gene 2796] {aka GNRH, GRH, LHRH, LNRH}, TCF12 (transcription factor 12) [NCBI Gene 6938] {aka CRS3, HEB, HH26, HTF4, HsT17266, TCF-12}
- **Diseases:** olfactory bulb hypoplasia (MESH:D000857), endocrinopathy (MESH:C567425), CHH (MESH:D007006), autosomal dominant craniosynostosis (MESH:D003398), Isolated Kallmann Syndrome (MESH:D017436), cryptorchidism (MESH:D003456), micropenis (MESH:C536649), hyposmia (MESH:D000086582)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.391-1G >A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12245484/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12245484/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12245484/full.md

---
Source: https://tomesphere.com/paper/PMC12245484